102 related articles for article (PubMed ID: 19876891)
1. No effect of irinotecan in patients with resistant desmoplastic small round cell tumor.
Bisogno G; Riccardi R; Scagnellato A; Arcamone G; Miglionico L; Carli M
Pediatr Blood Cancer; 2010 Jan; 54(1):182-3. PubMed ID: 19876891
[No Abstract] [Full Text] [Related]
2. Successful clinical response to irinotecan in desmoplastic round blue cell tumor.
Rosoff PM; Bayliff S
Med Pediatr Oncol; 1999 Nov; 33(5):500-3. PubMed ID: 10531577
[No Abstract] [Full Text] [Related]
3. Desmoplastic small round cell tumor--abdomen.
Kinra P; Pujahari AK
Indian J Pathol Microbiol; 2008; 51(3):449-50. PubMed ID: 18723992
[No Abstract] [Full Text] [Related]
4. A phase II window study of irinotecan (CPT-11) in high risk Ewing sarcoma: a Euro-E.W.I.N.G. study.
Morland B; Platt K; Whelan JS
Pediatr Blood Cancer; 2014 Mar; 61(3):442-5. PubMed ID: 24019263
[TBL] [Abstract][Full Text] [Related]
5. Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature.
Hamberg P; De Jong FA; Brandsma D; Verweij J; Sleijfer S
Acta Oncol; 2008; 47(5):974-8. PubMed ID: 17924208
[No Abstract] [Full Text] [Related]
6. [Preliminary study on the efficacy of irinotecan in the treatment of childhood relapsed hepatoblastoma].
Chang J; Zhang YT; Zhong XD; Wang LZ
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jul; 15(7):588-90. PubMed ID: 23866285
[No Abstract] [Full Text] [Related]
7. [Intra-abdominal desmoplastic small round cell tumor in childhood: case report and review of the literature].
Jellouli M; Mekki M; Krichene I; Zakhama A; Belghith M; Jouini R; Sahnoun L; Rammeh S; Harbi A; Nouri A
Bull Cancer; 2003 Dec; 90(12):1063-6. PubMed ID: 14715426
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors in childhood sarcomas of neuroectodermal histogenesis].
Budarin MA
Vopr Onkol; 2002; 48(3):335-9. PubMed ID: 12455358
[No Abstract] [Full Text] [Related]
9. Childhood desmoplastic fibroblastoma (collagenous fibroma) with a 12-year follow-up.
Magro G; Venti C
Pediatr Dev Pathol; 1999; 2(1):62-4. PubMed ID: 9841708
[TBL] [Abstract][Full Text] [Related]
10. Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11).
Palmer RD; Williams DM
Med Pediatr Oncol; 2003 Jul; 41(1):78-80. PubMed ID: 12764754
[No Abstract] [Full Text] [Related]
11. Desmoplastic fibroma of the frontal bone.
Lath R; Ranjan A; Ratnam BG; Gowrishankar S
Neurol India; 2006 Sep; 54(3):314-5. PubMed ID: 16936402
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma.
Bisogno G; Riccardi R; Ruggiero A; Arcamone G; Prete A; Surico G; Provenzi M; Bertolini P; Paolucci P; Carli M
Cancer; 2006 Feb; 106(3):703-7. PubMed ID: 16369989
[TBL] [Abstract][Full Text] [Related]
13. Irinotecan as maintenance therapy in high-risk hepatoblastoma.
Qayed M; Powell C; Morgan ER; Haugen M; Katzenstein HM
Pediatr Blood Cancer; 2010 May; 54(5):761-3. PubMed ID: 20063426
[TBL] [Abstract][Full Text] [Related]
14. Desmoplastic fibroma with perineural extension.
Moorjani V; Stockton V
AJR Am J Roentgenol; 2005 Dec; 185(6):1498-9. PubMed ID: 16304003
[No Abstract] [Full Text] [Related]
15. Response to vinorelbine and low-dose cyclophosphamide chemotherapy in two patients with desmoplastic small round cell tumor.
Ferrari A; Grosso F; Stacchiotti S; Meazza C; Zaffignani E; Marchianò A; Casanova M
Pediatr Blood Cancer; 2007 Nov; 49(6):864-6. PubMed ID: 16302215
[TBL] [Abstract][Full Text] [Related]
16. Imaging findings in desmoplastic fibroma of bone: distinctive T2 characteristics.
Frick MA; Sundaram M; Unni KK; Inwards CY; Fabbri N; Trentani F; Baccini P; Bertoni F
AJR Am J Roentgenol; 2005 Jun; 184(6):1762-7. PubMed ID: 15908527
[TBL] [Abstract][Full Text] [Related]
17. [[Irinotecan--experience with second-line treatment in advanced colorectal cancer] ].
Kristó K; Izsó J; Balatoni G; Lohinszky J; Farczádi E; Szántó J; Kofi AP; Pintér T
Orv Hetil; 2000 Aug; 141(33):1817-20. PubMed ID: 10979311
[TBL] [Abstract][Full Text] [Related]
18. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group.
Pappo AS; Lyden E; Breitfeld P; Donaldson SS; Wiener E; Parham D; Crews KR; Houghton P; Meyer WH;
J Clin Oncol; 2007 Feb; 25(4):362-9. PubMed ID: 17264331
[TBL] [Abstract][Full Text] [Related]
19. [Retrospective study on utility of irinotecan hydrochloride in patients with advanced and recurrent breast cancer].
Okubo S; Kurebayashi J; Sonoo H; Hirono M; Nomura N; Udagawa K; Yamamoto Y; Ikeda M; Nakashima K; Tanaka K
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1441-5. PubMed ID: 14584275
[TBL] [Abstract][Full Text] [Related]
20. [Irinotecan chemotherapy for patients with advanced or relapsed pancreatic neoplasm].
Sekikawa T; Akaike A; Ushio J; Sato A; Matsukawa M
Nihon Rinsho; 2006 Jan; 64 Suppl 1():203-6. PubMed ID: 16457250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
